Community Pharmacy England held a pharmacy event and spread the word more widely about the sector’s challenges and potential at this year’s Labour Party conference in Liverpool. This followed on from the Conservative Party conference which you can read about here and built on our ongoing work to ensure the Shadow Health Team are well
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Bumetanide 1mg and 5mg tablets. MSN/2023/094 Tier 3 – high impact Date of issue 12th October 2023 Bumetanide 5mg tablets are out of stock until early March 2024. Bumetanide 1mg tablets remain available until the end of October and will be
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Azithromycin (Azyter®) 15mg/g eye drops (0.25g unit dose, preservative free). MSN/2023/096 Tier 2 – medium impact Date of issue 12th October 2023 Azithromycin (Azyter®) 15mg/g eye drops are out of stock from mid-October to mid-November 2023. Alternative topical and oral antibiotics
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Pancrease® HL gastro-resistant capsules. MSN/2023/095 Tier 2 – medium impact Date of issue 12th October 2023 Pancrease® HL gastro-resistant capsules are being discontinued with stock expected to be exhausted by mid-November 2023. Alternative high strength pancreatin preparations remain available and will
Read moreChanges to the Human Medicines Regulations 2023 came into effect today (11th October) which provides new rules requiring pharmacists to dispense all licensed medicines containing valproate in the manufacturer’s original full pack. When dispensing valproate products, the pharmacist must supply the product as a complete pack. This will require them to round up or down
Read more
The NHS Business Services Authority (NHSBSA) has informed us that from 12 October 2023, the Manage Your Service (MYS) dashboard layout will be changing following user feedback. The changes will see the current tabs move to the left-hand side of the page and the tabs will be reordered and listed in alphabetical order. The image
Read morePolitical party conference season is now in full swing and over the last week Community Pharmacy England has been at the Conservative Party Conference in Manchester. We hosted an event with influential MPs, charities, local councillors and patient advocates, and we have been talking to wider contacts such as think tanks and journalists. We’ll be
Read moreCommunity Pharmacy England and others have contributed to a report examining the impact of workforce wellbeing on pharmacy teams and how it can be addressed. The Pharmacy Workforce Wellbeing Roundtable Report has been published by the Royal Pharmaceutical Society (RPS) and Pharmacist Support following a roundtable discussion held earlier this year. Community Pharmacy England Director
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Progesterone (Lutigest®) 100mg vaginal tablets and Progesterone (Crinone®) 8% progesterone vaginal gel. MSN/2023/093 Tier 2 – medium impact Date of issue 3rd October 2023 Progesterone (Lutigest®) 100mg vaginal tablets are out of stock until late December 2023. Progesterone (Crinone®) 8% progesterone
Read moreMolnlycke® Healthcare has confirmed that they have ceased manufacturing of all Mepilex® Border and Mepilex® Border Lite dressings (other products in the Mepilex® range are unaffected ). In the coming months, both dressings will deleted from the Appliances (Part IXA) section of the Drug Tariff. Once deleted from the Tariff any prescriptions for these dressings
Read more
